The 4 points where rare disease launches break down
In rare disease launches, every specialist interaction matters. Yet many organizations unintentionally create friction through misaligned priorities,…
6 Common pitfalls of L&D in pharma and what to do instead
This one-pager outlines 6 critical missteps that pharmaceutical Learning & Development teams often make, from launching training at the wrong time to relying on outdated success metrics. It’s ideal for L&D leads looking to boost commercial impact through behavior change and stronger field execution.
Explore other resources
All
- All
- One-Pager
- White Paper
The right-sized launch
When launch budgets shrink, training priorities become even more important. This one-pager outlines a practical framework for…
Are your medical and sales teams actually ready to launch together?
Most pharma launches fail not because the science is wrong, but because the people delivering it are…
The Cross‑Functional Collaboration Framework for Rare Disease Launches
Rare disease launches place extraordinary demands on the field. Medical, commercial, and market access teams are often…
Stay ahead of the game with regular updates
